Back to top

Avanir Pharmaceuticals (AVNR) in Focus: Stock Moves 6.1% Higher
May 15, 2014

Read MoreHide Full Article
Avanir Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise by over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained almost 59% since Apr 28.

This drugs manufacturer has seen one positive and one negative estimate revision over the past 30 days and its Zacks Consensus Estimate has gone down over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Avanir Pharmaceuticals has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.

Some better-ranked stocks in the same industry include Biomerica Inc. , Bio-Path Holdings, Inc. (BPTH - Free Report) and POZEN Inc. . All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Bio-Path Holdings, Inc. (BPTH) - free report >>

More from Zacks Tale of the Tape

You May Like